Striatal shape alteration as a staging biomarker for Parkinson’s Disease
Parkinson’s Disease provokes alterations of subcortical deep gray matter, leading to subtle changes in the shape of several subcortical structures even before the manifestation of motor and non-motor clinical symptoms. We used an automated registration and segmentation pipeline to measure this struc...
Main Authors: | Maxime Peralta, John S.H. Baxter, Ali R. Khan, Claire Haegelen, Pierre Jannin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | NeuroImage: Clinical |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213158220301091 |
Similar Items
-
Clinical application of circulating microRNAs in Parkinson's disease: The challenges and opportunities as diagnostic biomarker
by: Palaniswamy Ramaswamy, et al.
Published: (2020-01-01) -
Recent Advances in Biomarkers for Parkinson’s Disease
by: Runcheng He, et al.
Published: (2018-10-01) -
Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease
by: Tianbai Li, et al.
Published: (2018-11-01) -
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
by: Anna Santaella, et al.
Published: (2020-01-01) -
Biomarker Research in Parkinson’s Disease Using Metabolite Profiling
by: Jesper F. Havelund, et al.
Published: (2017-08-01)